Everolimus Show Significant Benefit in Patients with Non-cancerous Tumors Associated with Tuberous Sclerosis Complex (TSC)
Everyone's Blog Posts - Onco'Zine,
Results of a phase III study published in The Lancet shows that more than 40% of patients with Tuberous Sclerosis Complex (TSC…